Approach to prolonged viral pneumonia in immunocompromised patients with COVID-19
Open Access
- 25 June 2024
- journal article
- review article
- Published by Elsevier in CMI Communications
- Vol. 1 (2)
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Ensitrelvir in patients with SARS-CoV-2: A retrospective chart reviewJournal of Infection and Chemotherapy, 2024
- Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2024
- Persistent SARS-CoV-2 infection: significance and implicationsThe Lancet Infectious Diseases, 2024
- Organizing pneumonia and COVID-19The American Journal of the Medical Sciences, 2023
- Characteristics and risk factors of prolonged viable virus shedding in immunocompromised patients with COVID-19: a prospective cohort studyJournal of Infection, 2023
- COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysisJAMA Network Open, 2023
- Bronchoalveolar lavage in suspected COVID-19 cases with a negative nasopharyngeal swab: a retrospective cross-sectional study in a high-impact Northern Italy areaInternal and Emergency Medicine, 2021
- Differential Markers of Bacterial and Viral Infections in Children for Point-of-Care TestingTrends in Molecular Medicine, 2020
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19Cell, 2020
- The diagnostic accuracy of procalcitonin for bacteraemia: a systematic review and meta-analysisClinical Microbiology and Infection, 2015